Thermo Fisher Scientific Files Definitive Proxy Statement

Ticker: TMO · Form: DEFA14A · Filed: Apr 9, 2024 · CIK: 97745

Thermo Fisher Scientific Inc. DEFA14A Filing Summary
FieldDetail
CompanyThermo Fisher Scientific Inc. (TMO)
Form TypeDEFA14A
Filed DateApr 9, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, regulatory-filing, shareholder-meeting

Related Tickers: TMO

TL;DR

Thermo Fisher's proxy statement is out - get ready to vote on company matters.

AI Summary

Thermo Fisher Scientific Inc. filed a Definitive Proxy Statement (DEFA14A) on April 9, 2024. This document, filed under the 1934 Act, serves as the company's official proxy statement for its shareholders. It details information related to upcoming shareholder meetings and voting procedures.

Why It Matters

This filing is crucial for shareholders as it outlines the agenda and proposals for the company's annual meeting, enabling them to make informed voting decisions.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEFA14A) that provides information to shareholders and does not inherently carry significant financial risk.

Key Players & Entities

  • THERMO FISHER SCIENTIFIC INC. (company) — Filer of the DEFA14A
  • 0000097745-24-000015 (filing_id) — Accession number for the filing
  • 1934 Act (regulation) — Securities Exchange Act under which the filing is made
  • 168 THIRD AVENUE (address) — Company's business and mailing address
  • WALTHAM (city) — City of the company's address
  • MA (state) — State of the company's address
  • 02451 (zip_code) — Zip code of the company's address
  • 7816221000 (phone_number) — Company's business phone number

FAQ

What type of SEC filing is this?

This is a DEFA14A, a Definitive Proxy Statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934.

Who is the filer of this document?

The filer is THERMO FISHER SCIENTIFIC INC.

When was this filing made?

The filing was made on April 9, 2024.

What is the company's address listed in the filing?

The company's business and mailing address is 168 THIRD AVENUE, WALTHAM, MA 02451.

What is the accession number for this filing?

The accession number for this filing is 0000097745-24-000015.

Filing Stats: 131 words · 1 min read · ~1 pages · Grade level 12.2 · Accepted 2024-04-09 07:25:08

Filing Documents

From the Filing

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Rule 14a-101) SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.__ ) Filed by the Registrant Filed by a Party other than the Registrant CHECK THE APPROPRIATE BOX Preliminary Proxy Statement Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to Section 240.14a-12 Thermo Fisher Scientific Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY) No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.